Venus Remedies Limited — Important, 20-01-2025: Updates

Venus Remedies Limited has successfully renewed its European Good Manufacturing Practice (GMP) certification through the National Authority of Medicines and Health Products in Portugal. This certification pertains to its manufacturing facility for Cephalosporin, Carbapenem, and oncology formulations (both liquid and lyophilized injectables). The renewal not only reinforces the company's established position in the European market, where it has maintained a robust presence for over 15 years, but also emphasizes its commitment to delivering high-quality pharmaceutical products. This enhances its reputation among healthcare providers in the region, potentially paving the way for increased market trust and business opportunities. Investors should note the positive outlook as this positions the company favorably in the competitive pharmaceutical landscape.